MétaCan
Menu
Back to cohort
Record W4407285771 · doi:10.1093/jcag/gwae059.208

A208 MENTAL HEALTH, WORK IMPAIRMENT, AND MEDICATION SATISFACTION AMONGST INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE RECEIVING LONG-TERM BIOLOGIC AND ADVANCED TREATMENT

2025· article· en· W4407285771 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2025
Typearticle
Languageen
FieldMedicine
TopicMicroscopic Colitis
Canadian institutionsMount Sinai HospitalUniversity of Toronto
Fundersnot available
KeywordsInflammatory bowel diseaseMedicineDiseaseTerm (time)Mental healthPhysical therapyPsychiatryIntensive care medicineInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background Biologic and advanced immunotherapies have been shown to be effective in controlling biochemical, endoscopic, and histologic disease activity in individuals with Inflammatory Bowel Disease (IBD). However, there is limited data assessing the prevalence of somatic symptoms, mental health, and quality of life (QoL) in this population. To provide holistic care and appropriately manage both gut and somatic symptoms, it is critical to assess the prevalence of these symptoms and impairments. Aims This study assessed the prevalence of mental health deficits, quality of life, and work impairment in IBD patients who are being treated with biologic and advanced therapies for at least six months. The objective was to assess whether significant gaps in these domains persist as well as whether individuals are satisfied with their current advanced treatment. Methods Cross-sectional data was prospectively collected using a survey completed by individuals >18 years old, with a known diagnosis of Ulcerative Colitis, Crohn’s Disease, or Indeterminate Colitis, who have been receiving a biologic or advanced immunotherapy at a stable dose for >= 6 months. In addition to demographic data, the survey contained validated questionnaires assessing mental health, work impairment, and QoL. The presence of deficits in these domains was then evaluated using absolute scores and validated cutoffs. Results This study included 37 individuals who completed the survey as well as an additional 3 who completed part of it. 85% of respondents agreed that their current therapy has improved their symptoms and 62.5% of respondents are satisfied with their current treatment. 5.4-29.7% and 13.5-29.7% endorsed symptoms consistent with depression and anxiety respectively on different questionnaires. 51.4% of respondents endorsed active symptoms, and 56.8% endorsed symptom severity consistent with non-remission. A mean of 2.74 hours of weekly work productivity were lost due to IBD activity. Conclusions The majority of individuals with IBD on long-term advanced therapy report symptom improvement and satisfaction with their treatment. However, more than half endorsed ongoing symptoms of IBD, including work impairment, and nearly one-third endorsed mental health impairment consistent with depression or anxiety. This suggests that despite perceived treatment efficacy, significant gaps in these domains persist. Funding Agencies None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.164
Threshold uncertainty score0.850

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.246
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it